Labshake search
Citations for Stemcell Technologies :
1851 - 1900 of 4852 citations for Primary Human Aortic Endothelial Cells since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2020Quote: ... Human bone marrow CD34+ HPCs were obtained from Stem cell Technologies and recovered in SFEMII (Stem Cell Technologies) supplemented with 10% BIT 9500 serum substitute ...
-
bioRxiv - Developmental Biology 2021Quote: ... Cells were treated with Accutase (StemCell Technologies), rinsed in gut media and plated at a density of 3.6 million cells per well ...
-
bioRxiv - Neuroscience 2021Quote: ... or singularised using accutase (Stem Cell Technologies). To promote cell survival during enzymatic passaging ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/mL mEGF (#78016, Stem Cell Tech), 0.0002% Heparin Sulfate (#H7640 ...
-
bioRxiv - Cancer Biology 2021Quote: ... enzymatically digested with collagenase (Stem Cell Technologies) for 90 min at 37°C (Mueller et al. ...
-
bioRxiv - Systems Biology 2022Quote: ... with mTeSR1 supplement (Stem Cell Technologies, 05852) or mTeSR Plus (Stem Cell Technologies ...
-
bioRxiv - Neuroscience 2022Quote: ... 0.2 µM Compound E (Stem Cell Technologies), 1 µg/mL Laminin (R&D ...
-
bioRxiv - Cancer Biology 2022Quote: ... rh-FGF (Stem Cell Technologies, Cat #02634) and rh-EGF (Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: ... counted in ammonium chloride (Stem Cell Technologies) using the Vi-CELL XR viability analyzer (Beckman Coulter ...
-
bioRxiv - Developmental Biology 2019Quote: ... then dissociated in Accutase (Stem Cell Technologies) for 4 minutes 30 seconds at 37°C in 5% CO2 ...
-
bioRxiv - Developmental Biology 2019Quote: ... Medium was Myelocult H5100 (Stem Cell Technologies) supplemented with 100U/mL Penicillin and 0.1mg/mL Streptomycin (Sigma-Aldrich) ...
-
bioRxiv - Developmental Biology 2019Quote: ... was maintained in mTeSR1 (Stem Cell Technologies) on matrigel coated dishes at 37°C in 5% CO2 ...
-
bioRxiv - Neuroscience 2019Quote: ... Rock inhibitor (10 μM; Stem Cell Technologies) was added for up to 48 h ...
-
bioRxiv - Molecular Biology 2019Quote: ... and passaged by Accutase (Stem Cell Technologies) as described (Daneshvar et al. ...
-
bioRxiv - Cancer Biology 2019Quote: ... or Methocult-Optimum (H4035, Stem Cell Technologies) without EPO ...
-
bioRxiv - Systems Biology 2021Quote: ... 3 µM CHIR99021 (72054, Stem Cell Technologies) and 1 µM PD0325901 (72184 ...
-
bioRxiv - Cancer Biology 2019Quote: ... supplemented with StemSpan CC110 (Stem Cell Technologies), 35nM UM171 (Stem Cell Technologies ...
-
bioRxiv - Developmental Biology 2021Quote: ... CHIR99021 (C, 1 mM; Stem Cell Technologies), (S)-(+)-Dimethindenemaleate (D ...
-
bioRxiv - Immunology 2021Quote: ... anti-CD38 FITC (Stem Cell technologies, #60131FI) at a 1:200 dilution and the live/dead marker Zombie NIR at a 1:400 dilution in FACS buffer.
-
bioRxiv - Neuroscience 2019Quote: ... or ReLeSR passaging media (Stem Cell Technology). The anti-ATXN3 ASO and scrambled control ASO (ASO-Ctrl ...
-
bioRxiv - Genetics 2020Quote: ... dissociated with Accutase (Stem Cell Technologies, 7920), and added to fresh medium on a new plate and/or added to freezing medium for storage.
-
bioRxiv - Developmental Biology 2021Quote: ... cells were dissociated via Accutase (STEMCELL Technologies) and plated in 24 well plates covered with matrigel at 20,000 cells/per well and grown in basic differentiation media (advanced RPMI with Glutamax ...
-
bioRxiv - Neuroscience 2020Quote: ... and passaged using Dispase (Stem Cell Technologies) at RUCDR Infinite Biologics ...
-
bioRxiv - Cell Biology 2020Quote: cells were dissociated using Accutase (Stemcell Technologies) and 8 × 105 cells were electroporated using 5 mg of total DNA (Ratio 1:1 ...
-
bioRxiv - Developmental Biology 2021Quote: ... in mTeSR1 media (Stem Cell Technologies, 85870) using maintenance procedures developed by the Allen Institute for Cell Science (https://www.coriell.org/1/AllenCellCollection) ...
-
bioRxiv - Bioengineering 2021Quote: ... Cells were supplemented with ReproTeSR (STEMCELL Technologies) on alternate days starting from Day 3 without removing any medium from the well ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were singularized with Accutase (STEMCELL Technologies), counted using a Countess II FL (Life Technologies) ...
-
bioRxiv - Developmental Biology 2021Quote: ... with mTeSR1 supplement (Stem Cell Technologies, 05852) and supplemented with penicillin/streptomycin (P/S ...
-
bioRxiv - Developmental Biology 2021Quote: ... Cells were passaged using ReLeSR (STEMCELL Technologies) every 5 days ...
-
bioRxiv - Microbiology 2020Quote: ... Cells were passaged with ReleSR (STEMCELL Technologies) when cells reach approximately 80% confluence ...
-
bioRxiv - Immunology 2020Quote: ... B cells were purified magnetically (STEMCELL Technologies) and stained with anti-CD19 ...
-
bioRxiv - Immunology 2021Quote: ... Th17 cells were enriched (StemCell Technologies; 17862) from healthy donor human PBMCs and cultured in 96 well plates in IMDM supplemented with 10% FBS ...
-
bioRxiv - Genetics 2021Quote: Cells were grown in StemSpan (StemCell Technologies) supplemented with 0.5% P/S ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 μg/mL DNase (Stem Cell Technologies), and 10 μM Y27632 (Selleck ...
-
bioRxiv - Microbiology 2020Quote: ... in mTeSR1 medium (Stem Cell Technologies, 05850) at 37°C with 5% CO2 ...
-
bioRxiv - Neuroscience 2022Quote: ... Cells were passaged with ReLeSR (StemCell Technologies) or with Accutase (Sigma) ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2% SM1 supplement (Stem Cell Technologies), and subsequently fed with astrocyte-conditioned BrainPhys media (Stem Cell Technologies ...
-
bioRxiv - Molecular Biology 2022Quote: ... passed through a cell strainer (Stemcell Technologies) and analyzed using flow cytometry ...
-
bioRxiv - Cancer Biology 2022Quote: ... using ALDEFLUOR (Stem Cell Technologies, Seattle, WA) according to the manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... Cells were replated using ReLeSR (StemCell Technologies) at day 12 at 100,000 cells per 35 mm well (1 well of a 6 well plate) ...
-
bioRxiv - Neuroscience 2023Quote: ... 354234)-coated dishes containing (Stem Cell Technologies; 85850) with 4 μM ROCK inhibitor (Hölzel Diagnostik ...
-
bioRxiv - Neuroscience 2022Quote: ... and 1µM SB-431542 (Stem Cell Technologies).
-
bioRxiv - Neuroscience 2022Quote: ... cells were harvested with Accutase (StemCell technologies) and a subset (approximately 75,000 cells ...
-
bioRxiv - Neuroscience 2022Quote: ... and TGFß inhibitor SB431542 (Stem Cell Technologies) were added (final concentration of 3 μM and 5 μM ...
-
bioRxiv - Systems Biology 2022Quote: ... and 1 μM Dabrafenib (Stem Cell Technologies) to induce differentiation ...
-
bioRxiv - Systems Biology 2022Quote: ... with 10 μM DAPT (Stem Cell Technologies) and 1 μM Dabrafenib (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... CD8+ T cells were isolated (StemCell Technologies) from healthy human donor Leukopaks and expanded either on anti-CD3 coated plates (+anti-CD28/IL-2 ...
-
bioRxiv - Neuroscience 2022Quote: ... Cells were passaged with ReLeSR (StemCell Technologies) or Accutase (Sigma) ...
-
bioRxiv - Systems Biology 2024Quote: ... Heparin (2μg/ml) (Stem Cell Technologies #07980) and 1% Penicilin-Streptomycin Solution (Sigma-Aldrich P4458).
-
bioRxiv - Cancer Biology 2024Quote: ... 750 nM SR1 (Stem Cell Technologies #72344) and 35 nM UM171(Stem Cell Technologies #72912 ...